{"symbol": "NLNK", "companyName": "NewLink Genetics Corporation", "exchange": "NASDAQ Global Market", "industry": "Biotechnology", "website": "http://www.newlinkgenetics.com", "description": "NewLink Genetics Corp is a clinical stage immuno-oncology company based in US. It focuses on developing novel immunotherapeutic products for the treatment of cancer. Its portfolio contains biologic and small-molecule immuno-oncology product candidates.", "CEO": "Charles J. Link", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}